An approved sample is an important decision point, but it is often asked to carry more meaning than it can support. It proves that a particular result was achieved under a particular set of conditions. Unless those conditions are identified and transferred, the sample does not prove that the result will remain stable when the order moves into routine production.
The central buyer question is therefore not only, "Does this sample conform?" It is also, "Which material, process, tooling, inspection and external-provider conditions produced it—and how will those conditions be controlled after approval?"
The sample may have been made under exceptional conditions
Sample quantities are small. They may receive the most experienced operator, the preferred machine, additional manual fitting, repeated measurement or extra sorting. None of those actions is automatically improper during development. The risk appears when an exceptional method is not visible and cannot be repeated economically or consistently in production.
A dimensional report alone may not reveal this. The reported part can meet every measured value while the route behind it remains unsuitable for the planned quantity. Before approval, buyers should ask whether the sample used the intended production material, equipment, fixtures, program, outsourced processes and inspection method. If not, the difference should be recorded and closed through a production-representative trial.
Approve a baseline, not only a physical part
A stronger sample approval package links the accepted part with the information needed to reproduce it. The exact content depends on risk, but the baseline may include:
- drawing and specification revision;
- approved technical clarifications;
- material grade, condition and source status;
- manufacturing route and identified external processes;
- tooling, fixtures or key program revision;
- critical characteristics and inspection method;
- approved appearance reference where applicable;
- concessions or deviations and their expiry;
- packing and preservation requirements;
- changes that require notification or reapproval.
ASQ describes a quality plan as documentation that can identify standards, practices, resources, specifications, activity sequence, testing parameters, acceptance criteria, deliverables and required notifications for a product or contract. ASQ — Quality Plans The practical lesson is not that every small order needs a large formal package. It is that approval should preserve the conditions essential to repeat the result.
First article inspection is a production-transfer check
The phrase "first article" is used differently across industries. IAQG 9102 standardises FAI process and documentation requirements for aviation, space and defence products. IAQG also notes that the approach can be used in other sectors where a standardised FAI process is needed. IAQG — 9102 First Article Inspection Requirement
Outside a contractually specified standard, buyers should not claim that a particular FAI form is universally mandatory. They can still apply the underlying control logic: use a part from the intended production process to verify that the complete requirement has been understood and achieved before unrestricted production continues.
That normally requires more than checking a few critical dimensions. The review may need to confirm drawing accountability, material and process evidence, characteristic-level results, specified tests, approved deviations and the identity of the production route.
Define when production must pause
The first production batch is where economic and scheduling pressure becomes real. Material is purchased in production quantity, operators work to a normal cycle and external processors handle actual batches. This is the point at which hidden differences between the sample route and production route often become visible.
Buyers should therefore define a release gate. Depending on risk, the supplier may be required to produce the first units, complete agreed inspection, submit evidence and pause until approval. For lower-risk work, the gate may be a document review without a physical stop. For critical features or unproven processes, continuing the full batch before reviewing early evidence may make containment much more expensive.
The gate should answer four questions:
- Which units or batch constitute the first production evidence?
- Which characteristics and records must be reviewed?
- Who has authority to release continued production?
- What happens if the evidence does not meet the baseline?
Control changes that can invalidate approval
Approval loses value if the supplier can change the conditions behind it without review. Not every adjustment requires customer approval, but the parties should identify changes capable of affecting form, fit, function, appearance, reliability, compliance or traceability.
Typical triggers include a new material source or condition, a different production site, replacement tooling, a major program change, a different subcontractor, a revised heat-treatment or coating route, a change to the inspection method, a long interruption in production or a drawing revision.
The appropriate response may be notification, partial reinspection, a new first article or full requalification. The required response should reflect risk rather than applying the heaviest control to every change.
Do not let temporary deviations become the process
During sample and early production, buyers may accept a concession to protect schedule while a correction is completed. Such decisions need an identified part or batch, defined deviation, reason, approval authority and expiry condition.
Without those controls, a temporary deviation can quietly become the supplier's standard practice. Open corrective actions should therefore remain visible until implementation and effectiveness are confirmed. ASQ's description of the supplier corrective-action request process separates containment, root cause, implementation, effectiveness and closure—useful distinctions when a sample or early batch exposes a recurring risk. ASQ — Using the SCAR Document
A practical sample-to-production control sequence
- Confirm the requirement baseline before the sample is made.
- Record the actual route and conditions used for the approved sample.
- Identify differences between sample conditions and planned production.
- Close those differences through a production-representative run.
- Define first-production inspection evidence and release authority.
- Control material, process, site, tooling, subcontractor and inspection changes.
- Track deviations and corrective actions to verified closure.
- Retain an approved reference and records that can be used for repeat orders.
The approved sample remains useful. Its value increases when it is part of a controlled production baseline rather than the only evidence of readiness.
Buyer checklist
- Was the sample made to the current approved drawing and specification?
- Did it use production-intent material and material condition?
- Were production-intent equipment, tooling and fixtures used?
- Were external processes performed by the intended approved providers?
- Are critical characteristics and inspection methods agreed?
- Are any manual corrections or exceptional sorting steps recorded?
- What evidence must be approved before the full batch continues?
- Which changes trigger notification, reinspection or requalification?
- Are deviations limited to identified parts, batches and expiry conditions?
- Can the same baseline be retrieved for the next repeat order?
因此，買方不應只問「這件樣品是否合格」，還應追問：哪些材料、工藝、工裝、檢驗及外部供應方條件產生了這個結果？樣件批准後，這些條件將如何保持受控？
樣件可能在特殊條件下製作
樣件數量少，可能由經驗最豐富的操作人員使用優先設備製作，也可能經過額外手工修配、反覆測量或加嚴挑選。開發階段採取這些措施不一定錯誤；真正的風險，是特殊方法未被披露，而且在量產中無法經濟、穩定地重複。
單一尺寸報告未必能揭示這一點。報告中的零件可能所有測量值均合格，但背後製造路線並不適合計劃數量。批准前，買方應確認樣件是否使用量產意圖的材料、設備、工裝、程式、外協工序及檢驗方法。如有差異，應記錄並透過代表量產條件的試製加以關閉。
批准一套基線，而不只是一件實物
更可靠的樣件批准，會把獲批零件與重複製造該結果所需的資訊連接起來。具體內容取決於風險，通常可以包括：
- 圖紙及規格版本；
- 已獲批的技術澄清；
- 材料牌號、狀態及來源狀態；
- 製造路線及已識別外協工序；
- 工裝、夾具或關鍵程式版本；
- 關鍵特徵及檢驗方法；
- 適用時的外觀批准基準；
- 讓步或偏差及其失效條件；
- 包裝與防護要求；
- 需要通知或重新批准的變更。
ASQ對品質計劃的說明包括與特定產品或合同有關的標準、做法、資源、規格、活動順序、測試參數、驗收條件、交付物及通知要求。ASQ：品質計劃 這不代表每一筆小訂單都需要龐大文件，而是樣件批准至少要保存對重複結果至關重要的條件。
首件檢驗是量產轉移檢查
不同產業對「首件」的使用方式並不完全相同。IAQG 9102對航空、航太及國防產品的FAI流程與文件要求進行了標準化；IAQG同時指出，在其他需要標準化首件流程的產業也可以採用這一方法。IAQG：9102首件檢驗要求
如果合同沒有指定某一標準，買方不應聲稱特定首件表格對所有行業都具有強制性，但仍可採用其中的控制邏輯：使用來自預定量產工藝的零件，確認完整要求已被理解並實現，然後才允許不受限制地繼續生產。
這通常不只是檢查幾項關鍵尺寸，還可能包括圖紙要求對應、材料與工藝證據、逐項特徵結果、指定試驗、獲批偏差及生產路線身份。
明確量產應在哪裡暫停
第一批正式生產會真正承受成本與進度壓力：材料按量產數量採購、操作人員按照正常節拍工作，外部加工方處理實際批次。樣件路線與量產路線之間的隱藏差異，往往在這個節點才會顯現。
買方應設置放行關口。根據風險，可以要求供應商先完成首批單位、提交約定檢驗證據並暫停，待批准後再繼續。低風險項目可以只進行文件審查而不實際停線；對關鍵特徵或尚未證明的工藝，在審查早期證據前就完成整批生產，可能令後續圍堵成本大幅增加。
放行關口應回答：哪一批產品構成首批量產證據？需要審查哪些特徵與記錄？由誰批准繼續生產？如果證據不符合基線，應如何處理？
控制可能令批准失效的變更
如果供應商可以在未經審查的情況下改變樣件背後的條件，批准便失去價值。並非所有調整都需要客戶批准，但雙方應識別哪些變更可能影響形狀、配合、功能、外觀、可靠性、合規或追溯。
常見觸發項包括新的材料來源或狀態、不同生產場所、更換工裝、重大程式修改、更換外協方、修改熱處理或塗覆路線、改變檢驗方法、長時間停產後復產，以及圖紙版本變更。
對應措施可以是通知、局部復驗、新首件或完整重新確認，應根據風險選擇，而不是對所有變更一律採用最重控制。
不要讓臨時偏差變成正式工藝
在樣件和早期量產階段，買方有時會為保障進度，在完成永久修正前接受一次讓步。這類決定需要明確對應零件或批次、偏差內容、原因、批准權限及失效條件。
缺乏這些控制時，臨時偏差可能悄悄變成供應商的常規做法。未關閉的糾正措施應保持可見，直到實施及有效性得到確認。ASQ對供應商糾正措施請求的說明，將圍堵、根本原因、實施、有效性和關閉分開處理，適合用於樣件或首批生產暴露出的重複性風險。ASQ：SCAR文件的使用
從樣件轉入量產的控制順序
- 樣件製作前確認要求基線。
- 記錄獲批樣件實際使用的路線和條件。
- 識別樣件條件與計劃量產之間的差異。
- 透過代表量產條件的試製關閉差異。
- 定義首批量產檢驗證據及放行權限。
- 控制材料、工藝、場所、工裝、外協方及檢驗變更。
- 把偏差和糾正措施追蹤到已驗證關閉。
- 保留可供重複訂單使用的獲批基準及記錄。
獲批樣件仍然非常有用。當它成為受控量產基線的一部分，而不是唯一的量產準備證據時，其價值才會最大化。
買方檢查清單
- 樣件是否按照當前獲批圖紙及規格製作？
- 是否使用量產意圖的材料及材料狀態？
- 是否使用量產意圖的設備、工裝及夾具？
- 外協工序是否由預定的獲批單位完成？
- 關鍵特徵及檢驗方法是否已約定？
- 手工修正或特殊挑選是否已記錄？
- 完整批次繼續前需要批准哪些證據？
- 哪些變更會觸發通知、復驗或重新確認？
- 偏差是否限於已識別零件、批次及失效條件？
- 下一次重複訂單能否調取相同基線？